|
Medication errors in hematology-oncology ward by consultation : the role of the clinical pharmacologist
|
Ali Eishy Oskoyi    , Hamdollah Sharifi , Rahim Asghari |
| Inpatients Safety Research Center, Urmia University of Medical Sciences, Urmia , Iran , Sharifi.h@umsu.ac.ir |
|
|
Abstract: (2691 Views) |
Background: The aim was to describe, evaluate and document the prevention of medication errors by clinical pharmacologist consultations in patients with cancer.
Methods: We assessed the effect of clinical pharmacologist consultation by the acceptance of interventions recommended due to dosage, frequency, duration of therapy errors and drug-drug interactions (DDIs). All medication errors detected by clinical pharmacologist were reported in the format of medical consultation. A documentation template was designed to collect the patient’s data (sex, age, and diagnosis), prescriptions written, and drug-specific recommendations. For the descriptive analysis of medication errors, the unit of analysis was the number and percentage of errors.
Results: A total of 296 patients included in this study with a median age of 48.67±19.76 years of which 47.30% were females. 936 prescribing errors were detected and recommended for their correction. The specialist physicians accepted 897 of prescribed errors. DDIs that were detected in 66.22% of patients, were the most errors in this group of errors (47%). Improper dose (17.41%) wrong frequency (16.67%) and drug-food interaction (10.26%) were after that.
Conclusion: Pharmacological consultation in the hematology-oncology ward revealed many medication errors. The trust of physicians in the views of the clinical pharmacologist led to a large part of these errors being accepted and resolved. |
|
| Keywords: clinical pharmacologist, medication error, patient safety |
|
|
Full-Text [PDF 254 kb]
(456 Downloads)
|
Type of Study: Original Article |
Subject:
pharmacology
Received: 2019/03/5 | Accepted: 2020/01/7 | Published: 2021/01/21
|
|
|
|
|
|
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
